Drugs / CMS-D001
Trials 2
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 21 trial | ||||||
| Phase 2 | NCT07465120 | Mar 2026 → Jan 2027 expected | atopic eczema | Dermavon Holdings Limited | Not yet recruiting | No outcome recorded |
| Phase 2/31 trial | ||||||
| Phase 2/3 | NCT07432854 | Mar 2026 → Feb 2028 expected | psoriasis | Dermavon Holdings Limited | Not yet recruiting | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | CMS-D001 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07465120 ↗ |